Zeo ScientifiX Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 20

Employees

  • Stock Symbol
  • ZEOX

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $2.60
  • (As of Tuesday Closing)

Zeo ScientifiX General Information

Description

Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).

Contact Information

Formerly Known As
Bespoke Tricycles Inc., Biotech Products Services and Research, Organicell Regenerative Medicine, Inc., Biotech Products Services & Research, Inc.
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1951 North West 7th Avenue
  • Suite 300
  • Miami, FL 33136
  • United States
+1 (888)
Primary Industry
Biotechnology
Other Industries
Recreational Goods
Drug Discovery
Stock Exchange
PINX
Vertical(s)
Corporate Office
  • 1951 North West 7th Avenue
  • Suite 300
  • Miami, FL 33136
  • United States
+1 (888)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zeo ScientifiX Stock Performance

As of 25-Mar-2025, Zeo ScientifiX’s stock price is $2.60. Its current market cap is $16.5M with 6.34M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.60 $2.65 $0.80 - $4.73 $16.5M 6.34M 3.36K -$0.78

Zeo ScientifiX Financials Summary

As of 31-Jan-2025, Zeo ScientifiX has a trailing 12-month revenue of $4.56M.

In Thousands,
USD
TTM 31-Jan-2025 FY 2024 31-Oct-2024 FY 2023 31-Oct-2023 FY 2022 31-Oct-2022
EV 16,659 10,773 13,054 41,334
Revenue 4,556 4,620 4,558 6,491
EBITDA (4,748) (4,539) (6,070) (8,166)
Net Income (4,908) (4,705) (6,987) (8,897)
Total Assets 1,550 1,643 2,782 6,201
Total Debt 697 693 693 1,038
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Zeo ScientifiX Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zeo ScientifiX‘s full profile, request access.

Request a free trial

Zeo ScientifiX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collabora
Biotechnology
Miami, FL
20 As of 2024

South San Francisco, CA
 

Miramar, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zeo ScientifiX Competitors (4)

One of Zeo ScientifiX’s 4 competitors is Denali Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Denali Therapeutics Formerly VC-backed South San Francisco, CA
Kimera Labs Corporation Miramar, FL
Direct Biologics Venture Capital-Backed Austin, TX
Invitrx Therapeutics Corporation Austin, TX
To view Zeo ScientifiX’s complete competitors history, request access »

Zeo ScientifiX Patents

Zeo ScientifiX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230277588-A1 Compositions and methods for treating pain with extracellular vesicles Active 08-Dec-2021
CA-3242248-A1 Compositions and methods for treating pain with extracellular vesicles Pending 08-Dec-2021
US-12213994-B2 Compositions and methods for treating pain with extracellular vesicles Active 08-Dec-2021
EP-4132548-A1 Compositions comprising nanoparticles, method of making and uses thereof Pending 10-Apr-2020
AU-2021253889-A1 Compositions comprising nanoparticles, method of making and uses thereof Pending 10-Apr-2020 A61K35/50
To view Zeo ScientifiX’s complete patent history, request access »

Zeo ScientifiX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Zeo ScientifiX Investments (1)

Zeo ScientifiX’s most recent deal was a Corporate with Exotropin. The deal was made on 01-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Exotropin 01-Jan-2023 Corporate Other Pharmaceuticals and Biotechnology
To view Zeo ScientifiX’s complete investments history, request access »

Zeo ScientifiX FAQs

  • When was Zeo ScientifiX founded?

    Zeo ScientifiX was founded in 2011.

  • Where is Zeo ScientifiX headquartered?

    Zeo ScientifiX is headquartered in Miami, FL.

  • What is the size of Zeo ScientifiX?

    Zeo ScientifiX has 20 total employees.

  • What industry is Zeo ScientifiX in?

    Zeo ScientifiX’s primary industry is Biotechnology.

  • Is Zeo ScientifiX a private or public company?

    Zeo ScientifiX is a Public company.

  • What is Zeo ScientifiX’s stock symbol?

    The ticker symbol for Zeo ScientifiX is ZEOX.

  • What is the current stock price of Zeo ScientifiX?

    As of 25-Mar-2025 the stock price of Zeo ScientifiX is $2.60.

  • What is the current market cap of Zeo ScientifiX?

    The current market capitalization of Zeo ScientifiX is $16.5M.

  • What is Zeo ScientifiX’s current revenue?

    The trailing twelve month revenue for Zeo ScientifiX is $4.56M.

  • Who are Zeo ScientifiX’s competitors?

    Denali Therapeutics, Kimera Labs, Direct Biologics, and Invitrx Therapeutics are competitors of Zeo ScientifiX.

  • What is Zeo ScientifiX’s annual earnings per share (EPS)?

    Zeo ScientifiX’s EPS for 12 months was -$0.78.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »